Advertisement

Association between Genes for Inflammatory Factors and Neuroticism, Anxiety, and Depression in Men with Ischemic Heart Disease

  • V. E. Golimbet
  • B. A. Volel’
  • G. I. Korovaitseva
  • S. V. Kasparov
  • N. V. Kondrat’ev
  • F. Yu. Kopylov
Article

Objectives. To study the relationship between the immune system and depression, as well as its endophenotypes (neuroticism and trait anxiety), in patients with ischemic heart disease (IHD). Materials and methods. Studies were performed in a group of men with IHD and depression (78 patients) and without depression (91 patients), as well as in healthy male volunteers (127 subjects). Polymorphisms of the interleukin-4 (IL-4 –589C/T), interleukin-6 (IL-6 –174G/C), tumor necrosis factor α (TNF-α –308G/A), and C-reactive protein (CRP –717A/G) genes were studied. Results. An association between the IL-6 –174G/C polymorphism with depression comorbid with IHD was found (p = 0.01, OR = 2.3, 95% CI = 1.2–4.3), which was apparent as an increase in the frequency of the highly expressed G allele in the group of patients with depression. The IL-4 –589C/T polymorphism was associated with IHD: the frequency of the CC IL-4 –589C/T genotype was greater in this group of patients than in the control group regardless of the presence of depression (p = 0.007, OR = 2.1, 95% CI = 1.2–3.4). The TNF-α –308G/A and CRP –717A/G polymorphisms were not associated with depression in IHD. There were no signifi cant differences in the expression of neuroticism or trait anxiety in carriers of different genotypes at the IL-4 –589C/T, IL-6 –174G/C, TNF-α –308G/A, or CRP –717A/G loci. Conclusions. The association between the IL-6 –174G/C polymorphism with depression comorbid with IHD is consistent with published data on the role of IL-6 in the depression of depression in cardiology patients.

Keywords

IL-4 IL-6 TNF-α C-reactive protein IHD depression infl ammation markers 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    D. M. Moreira, R. L. da Silva, J. L. Vieira, T. Fattah, M. E. Lueneberg, and C. A. Gottschall, “Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease,” Am. J. Cardiovasc. Drugs, 15, No. 1, 1–11 (2015), doi:  https://doi.org/10.1007/s40256-014-0094-z.CrossRefPubMedGoogle Scholar
  2. 2.
    A. S. Tiganov, G. I. Kopeiko, O. S. Brusov, and T. P. Klyushnik, “A new study of the pathogenesis and treatment of endogenous depression,” Zh. Nevrol. Psikhiatr. im. S. S. Korsakova, 112, No. 11, 65–72 (2012).PubMedGoogle Scholar
  3. 3.
    N. Yu. Shimokhina, A. A. Savchenko, M. M. Petrova, and M. S. Chernyaeva (Pilyugina), “The state of the hemostasis and immune systems in patients with acute coronary syndrome combined with anxious-depressive disorders,” Kardiologiya, 55, No. 8, 12–20 (2015).CrossRefGoogle Scholar
  4. 4.
    N. G. Neznanov, S. N. Kozlova, G. E. Mazo, E. V. Shlyakhto, and B. I. Smirnov, “Comorbidity of depressive disorders with ischemic heart disease: common aspects of pathogenesis,” Zh. Nevrol. Psikhiatr. im. S. S. Korsakova, 115, No. 5, 20–26 (2015).CrossRefGoogle Scholar
  5. 5.
    N. Nikkheslat, P. A. Zunszain, M. A. Horowitz, I. G. Barbosa, J. A. Par ker, A. M. Myint, M. J. Schwarz, A. T. Tylee, L. A. Carvalho, and C. M. Pariante, “Insufficient glucocorticoid signaling and elevated inflammation in coronary heart disease patients with comorbid depression,” Brain Behav. Immun. (2015), pii: S0889-1591(15) 00020-3, doi:  https://doi.org/10.1016/j.bbi.2015.02.002.CrossRefGoogle Scholar
  6. 6.
    A. Steptoe, A. Wikman, G. J. Molloy, N. Messerli-Burgy, and J. C. Kaski, “Inflammation and symptoms of depression and anxiety in patients with acute coronary heart disease,” Brain Behav. Immun., 31, 183–188 (2013), doi:  https://doi.org/10.1016/j.bbi.2012.09.002.CrossRefGoogle Scholar
  7. 7.
    K. Millar, S. M. Lloyd, J. S. McLean, G. D. Batty, H. Burns, J. Cavanagh, K. A. Deans, I. Ford, A. McConnachie, A. McGinty, R. Mottus, C. J. Packard, N. Sattar, P. G. Shiels, Y. N. Velupillai, and C. Tannahill, “Personality, socio-economic status and inflammation: cross-sectional, population-based study,” PLoS One, 8, No. 3, e58256 (2013),  https://doi.org/10.1371/journal.pone.0058256.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    T. Pawlowski, M. Radkowski, K. Małyszczak, M. Inglot, M. Zalewska, J. Jablonska, and T. Laskus, “Depression and neuroticism in patients with chronic hepatitis C: correlation with peripheral blood mononuclear cells activation,” J. Clin. Virol., 60, No. 2, 105–111 (2014), doi:  https://doi.org/10.1016/j.jcv.2014.03.004.CrossRefPubMedGoogle Scholar
  9. 9.
    L. J. Rosenwasser and L. Borish, “Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10),” Am. J. Respir. Crit. Care Med., 156, 152–155 (1997),  https://doi.org/10.1164/ajrccm.156.4.12tac-14.CrossRefGoogle Scholar
  10. 10.
    I. Hagel, M. C. Di Prisco, J. Goldblatt, and P. N. Le Souëf, “The role of parasites in genetic susceptibility to allergy: IgE, helminthic infection and allergy, and the evolution of the human immune system,” Clin. Rev. Allergy Immunol., 26, 75-83 (2004),  https://doi.org/10.1385/criai:26:2:075.Google Scholar
  11. 11.
    D. Fishman, G. Faulds, R. Jeffery, V. Mohamed-Ali, J. S. Yudkin, S. Humphries, and P. Woo, “The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis,” J. Clin. Invest., 102, 1369–1376 (1998),  https://doi.org/10.1172/jci2629.CrossRefGoogle Scholar
  12. 12.
    S. J. Bull, P. Huezo-Diaz, E. B. Binder, J. F. Cubells, G. Ranjith, C. Maddock, C. Miyazaki, N. Alexander, M. Hotopf, A. J. Cleare, S. Norris, E. Cassidy, K. J. Aitchison, A. H. Miller, and C. M. Pariante, “Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment,” Mol. Psychiatry, 4, No. 12, 1095–1104 (2009), doi:  https://doi.org/10.1038/mp.2008.48.CrossRefGoogle Scholar
  13. 13.
    M. Tartter, C. Hammen, J. E. Bower, P. A. Brennan, and S. Cole, “Effects of chronic interpersonal stress exposure on depressive symptoms are moderated by genetic variation at IL6 and IL1β in youth,” Brain Behav. Immun. (2015); pii: S0889–1591(15)00005-7, doi:  https://doi.org/10.1016/j.bbi.2015.01.003.CrossRefGoogle Scholar
  14. 14.
    L. J. Abraham and K. M. Kroeger, “Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease,” J. Leukoc. Biol., 66, No. 4, 562–566 (1999).CrossRefGoogle Scholar
  15. 15.
    T. Y. Jun, C. U. Pae, H. Hoon, J. H. Chae, W. M. Bahk, K. S. Kim, and A. Serretti, “Possible association between _G308A tumour necrosis factor-alpha gene polymorphism and major depressive disorder in the Korean population,” Psychiatr. Genet., 13, 179–181 (2003),  https://doi.org/10.1097/00041444-200309000-00008.
  16. 16.
    J. M. Kim, R. Stewart, S. W. Kim, I. S. Shin, J. T. Kim, M. S. Park, S. W. Park, Y. H. Kim, K. H. Cho, and J. S. Yoon, “Associations of cytokine gene polymorphisms with post-stroke depression,” World J. Biol. Psychiatry, 12, No. 8, 579–587 (2012),  https://doi.org/10.3109/15622975.2011.588247.CrossRefGoogle Scholar
  17. 17.
    L. Wang, X. Lu, Y. Li, H. Li, S. Chen, and D. Gu, “Functional analysis of the C-reactive protein (CRP) gene –717A>G polymorphism associated with coronary heart disease,” BMC Med. Genet., 10, 73 (2009),  https://doi.org/10.1186/1471-2350-10-73.
  18. 18.
    D. Kotlęga, M. Białecka, M. Kurzawski, M. Droździk, S. Ciećwież, M. Gołąb- Janowska, and P. Nowacki, “Risk factors of stroke and –717A>G (rs2794521) CRP gene polymorphism among stroke patients in West Pomerania province of Poland,” Neurol. Neurochir. Pol., 48, No. 1, 30–34 (2014), doi:  https://doi.org/10.1016/j.pjnns.2013.12.001.CrossRefPubMedGoogle Scholar
  19. 19.
    E. Flores-Alfaro, G. Fernandez-Tilapa, E. Salazar-Martinez, M. Cruz, B. Illades-Aguiar, and I. Parra-Rojas, “Common variants in the CRP gene are associated with serum C-reactive protein levels and body mass index in healthy individuals in Mexico,” Genet. Mol. Res., 11, No. 3, 2258–2267 (2012), doi:  https://doi.org/10.4238/2012.May.14.5.CrossRefPubMedGoogle Scholar
  20. 20.
    M. Tajfard, L. A. Latiff, H. R. Rahimi, M. Mouhebati, H. Esmaeily, A. Taghipour, E. Mahdipour, H. Davari, Z. Saghiri, P. Hanachi, M. Ghayour Mobarhan, G. A. Ferns, and M. Azizian, “Serum inflammatory cytokines and depression in coronary artery disease,” Iran. Red Crescent Med. J., 16, No. 7, 17111 (2014), doi:  https://doi.org/10.5812/ircmj.17111.CrossRefGoogle Scholar
  21. 21.
    S. A. Hiles, A. L. Baker, T. de Malmanche, M. McEvoy, M. Boyle, and J. Attia, “The role of inflammatory markers in explaining the association between depression and cardiovascular hospitalisations,” J. Behav. Med., 38, No. 4, 609–619 (2015),  https://doi.org/10.1007/s10865-015-9637-2.CrossRefGoogle Scholar
  22. 22.
    M. Udina, J. Moreno-Espana, R. Navines, D. Gimenez, K. Langohr, M. Gratacos, L. Capuron, R. de la Torre, R. Sola, and R. Martin-Santos, “Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms,” Psychoneuroendocrinology, 38, No. 9, 1803– 1813 (2013), doi:  https://doi.org/10.1016/j.psyneuen.2013.03.007.CrossRefPubMedGoogle Scholar
  23. 23.
    S. W. Cole, J. M. Arevalo, R. Takahashi, E. K. Sloan, S. K. Lutgendorf, A. K. Sood, J. F. Sheridan, and T. E. Seeman, “Computational identifi cation of gene-social environment interaction at the human IL6 locus,” Proc. Natl. Acad. Sci. USA, 107, No. 12, 5681–5686 (2010), doi:  https://doi.org/10.1073/pnas.0911515107.CrossRefPubMedGoogle Scholar
  24. 24.
    L. Ghazouani, N. Abboud, S. Ben Hadj Khalifa, F. Added, A. Ben Khalfallah, B. Nsiri, M. Mediouni, and T. Mahjoub, “–174G>C interleukin-6 gene polymorphism in Tunisian patients with coronary artery disease,” Ann. Saudi Med., 31, 40–44 (2011), doi:  https://doi.org/10.4103/0256-4947.75777.CrossRefGoogle Scholar
  25. 25.
    C. Sekuri, F. S. Cam, A. Sagcan, E. Ercan, I. Tengiz, E. Alioglu, and A. Berdeli, “No association of interleukin-6 gene polymorphism (–174G/C) with premature coronary artery disease in a Turkish cohort,” Coron. Artery Dis., 18, 333–337 (2007),  https://doi.org/10.1097/mca.0b013e32820588ae.CrossRefGoogle Scholar
  26. 26.
    G. Q. Sun, G. D. Wu, Y. Meng, B. Du, and Y. B. Li, “IL-6 gene promoter polymorphisms and risk of coronary artery disease in a Chinese population,” Genet. Mol. Res., 13, No. 3, 7718–7724 (2014), doi:  https://doi.org/10.4238/2014.September.26.9.CrossRefPubMedGoogle Scholar
  27. 27.
    A. Phulukdaree, S. Khan, P. Ramkaran, R. Govender, D. Moodley, and A. A. Chuturgoon, “The interleukin-6 –147 g/c polymorphism is associated with increased risk of coronary artery disease in young South African Indian men,” Metab. Syndr. Relat. Disord., 11, 205–209 (2013,  https://doi.org/10.1089/met.2012.0130.CrossRefGoogle Scholar
  28. 28.
    H. Hou, C. Wang, F. Sun, L. Zhao, A. Dun, and Z. Sun, “Association of interleukin-6 gene polymorphism with coronary artery disease: an updated systematic review and cumulative meta-analysis,” Infl amm. Res., 64, No. 9, 707–720 (2015), doi:  https://doi.org/10.1007/s00011-015-0850-9.CrossRefGoogle Scholar
  29. 29.
    E. Paffen, P. Medina, M. C. de Visser, A. van Wijngaarden, E. Zorio, A. Estelles, F. R. Rosendaal, F. Espana, R. M. Bertina, and C. J. Doggen, “The –589C>T polymorphism in the interleukin-4 gene (IL-4) is associated with a reduced risk of myocardial infarction in young individuals,” J. Thromb. Haemost., 10, 1633–1638 (2008), doi:  https://doi.org/10.1111/j.1538-7836.2008.03096.x.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • V. E. Golimbet
    • 1
  • B. A. Volel’
    • 2
  • G. I. Korovaitseva
    • 1
  • S. V. Kasparov
    • 1
  • N. V. Kondrat’ev
    • 1
  • F. Yu. Kopylov
    • 2
  1. 1.Scientific Center for Mental HealthMoscowRussia
  2. 2.Sechenov First Moscow State Medical UniversityMoscowRussia

Personalised recommendations